We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Increased Bleb Formation Characterizes Metastatic Cancer Cells

By LabMedica International staff writers
Posted on 04 Jun 2019
A recent paper described an inexpensive fluid biopsy device that is able to distinguish highly metastatic prostate cancer cells from moderately metastatic prostate cancer cells and normal cells.

Since most prostate tumor cells that survive current treatment regimens become metastatic, there is an urgent need for new tools to detect metastatic prostate cancer that do not rely on prostate specific antigen (PSA) measurements, which cannot accurately identify cells with metastatic potential.

Plasma membrane blebbing (in which portions of the cell’s outer layer bulges outward from the more rigid inner layer) is known to provide important metastatic capabilities to cancer cells by aiding cell detachment from the primary tumor site and increasing cell deformability to promote cell migration through the extracellular matrix. More...
In fact, highly metastatic prostate cancer cells flowing through a microfluidic channel form 27% more plasma membrane blebs than normal cells and have a lower stiffness (about 50%).

Taking advantage of this property, investigators at Texas Tech University (Lubbock, USA) developed an instrument that measured bleb formation as the device forced cell samples through minute channels less than 10 microns wide. Results obtained by this method revealed that highly metastatic prostate cancer cells exhibited more blebbing than did moderately metastatic or normal cells. Of the highly metastatic cells 56% produced blebs, whereas only 29% of normal cells and 38% of moderately metastatic cells did.

Mechanistically, increased blebbing by highly metastatic cells was attributed to low levels of the protein F-actin, which resulted in a reduced number of binding sites for proteins that normally anchor the cell’s plasma membrane to the inner cortex.

“This is a potentially significant finding which may provide simple and inexpensive diagnostic methods for detecting early and advanced cancer, particularly metastatic cancer,” said senior author Dr. Fazle Hussain, professor of mechanical engineering at Texas Tech University.

The fluid biopsy device for detection of highly metastatic prostate cancer cells was described in the May 21, 2019, online edition of the journal Biomicrofluidics.

Related Links:
Texas Tech University


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: Automated cell imaging discriminates CD8+ T cells according to natalizumab treatment outcome in MS patients (B Chaves et al., Nat Commun 16, 5533 (2025). DOI: 10.1038/s41467-025-60224-3)

Novel Tool Predicts Most Effective Multiple Sclerosis Medication for Patients

Multiple sclerosis (MS) is a chronic autoimmune and degenerative neurological disease that affects the central nervous system, leading to motor, cognitive, and mental impairments. Symptoms can include... Read more

Industry

view channel
Image: ELITechGroup’s unique Real-Time PCR technologies include the revolutionary Minor Groove Binder (Photo courtesy of ELITechGroup)

ELITech and Hitachi High-Tech to Develop Automated PCR Testing System for Infectious Diseases

Molecular testing has become central to diagnosing and monitoring infectious diseases by analyzing genetic information. The use of PCR during the COVID-19 pandemic showed its value, but traditional systems... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.